Videos / Protein based COVID-19 vaccine
In this Product Explainer, Infectious Disease Physician and Clinical Microbiologist A/Prof Paul Griffin explains the recombinant protein nanoparticle COVID-19 vaccine with a proprietary adjuvant, including the mechanism of action, efficacy, and tolerability; and provides an update on boosters, indications, and access
(8 mins).

GLP 1s & Sarcopenia: Fact vs Hype

The New Dengue Vaccine – What You Need to Know

Hypertriglyceridaemia – Causes, Assessment & Management of CV Risk

Management of Photoageing

expert
Infectious Diseases Physician and Clinical Microbiologist; Director of Infectious Diseases, Mater Hospital; Lecturer, University of Queensland